{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease (AD)", "acetylcholinesterase (AChE)", "floribundiquinone B (FB)", "fluorescence quenching", "plant inhibitor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28915661", "DateCompleted": {"Year": "2017", "Month": "09", "Day": "25"}, "DateRevised": {"Year": "2019", "Month": "01", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "07", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.18632/oncotarget.19169"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "8", "Issue": "34", "PubDate": {"Year": "2017", "Month": "Aug", "Day": "22"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity.", "Pagination": {"StartPage": "57149", "EndPage": "57162", "MedlinePgn": "57149-57162"}, "Abstract": {"AbstractText": ["Being a neurodegenerative disorder, Alzheimer's disease (AD) is the one of the most terrible diseases. And acetylcholinesterase (AChE) is considered as an important target for treating AD. Acetylcholinesterase inhibitors (AChEI) are considered to be one of the effective drugs for the treatment of AD. The aim of this study is to find a novel potential AChEI as a drug for the treatment of AD. In this study, instead of using the synthetic compounds, we used those extracted from plants to investigate the interaction between floribundiquinone B (FB) and AChE by means of both the experimental approach such as fluorescence spectra, ultraviolet-visible (UV-vis) absorption spectrometry, circular dichroism (CD) and the theoretical approaches such as molecular docking. The findings reported here have provided many useful clues and hints for designing more effective and less toxic drugs against Alzheimer's disease."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}, {"Identifier": [], "Affiliation": "Gordon Life Science Institute, Boston, MA 02478, USA."}], "LastName": "Niu", "ForeName": "Bing", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}], "LastName": "Zhang", "ForeName": "Mengying", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, The First People's Hospital of Foshan, Foshan, 528000, China."}], "LastName": "Du", "ForeName": "Pu", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}], "LastName": "Jiang", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology, Affiliated Minzu Hospital of Guangxi Medical University, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530001, China."}], "LastName": "Qin", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}], "LastName": "Su", "ForeName": "Qiang", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}], "LastName": "Chen", "ForeName": "Fuxue", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, 200444, China."}, {"Identifier": [], "Affiliation": "Department of Life Science, Heze University, Heze, Shandong, 274500, China."}], "LastName": "Du", "ForeName": "Dongshu", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Otolaryngology-Head and Neck Surgery, Eye and Ear, Nose, Throat, Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China."}], "LastName": "Shu", "ForeName": "Yilai", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China."}, {"Identifier": [], "Affiliation": "Gordon Life Science Institute, Boston, MA 02478, USA."}], "LastName": "Chou", "ForeName": "Kuo-Chen", "Initials": "KC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "CoiStatement": "CONFLICTS OF INTEREST The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3:186\u2013191.", "ArticleIdList": ["19595937"]}, {"Citation": "Chou KC. An unprecedented revolution in medicinal chemistry driven by the progress of biological science. Curr Top Med Chem. 2017 Apr;14  https://doi.org/10.2174/1568026617666170414145508 [Epub ahead of print]", "ArticleIdList": ["10.2174/1568026617666170414145508", "28413951"]}, {"Citation": "Schnell JR, Chou JJ. Structure and mechanism of the M2 proton channel of influenza A virus. Nature. 2008;451:591\u2013595.", "ArticleIdList": ["PMC3108054", "18235503"]}, {"Citation": "Berardi MJ, Shih WM, Harrison SC, Chou JJ. Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching. Nature. 2011;476:109\u2013113.", "ArticleIdList": ["PMC3150631", "21785437"]}, {"Citation": "OuYang B, Xie S, Berardi MJ, Zhao XM, Dev J, Yu W, Sun B, Chou JJ. Unusual architecture of the p7 channel from hepatitis C virus. Nature. 2013;498:521\u2013525.", "ArticleIdList": ["PMC3725310", "23739335"]}, {"Citation": "Oxenoid K, Dong YS, Cao C, Cui T, Sancak Y, Markhard AL, Grabarek Z, Kong L, Liu Z, Ouyang B, Cong Y, Mootha VK, Chou JJ. Architecture of the Mitochondrial Calcium Uniporter. Nature. 2016;533:269\u2013273.", "ArticleIdList": ["PMC4874835", "27135929"]}, {"Citation": "Dev J, Park D, Fu Q, Chen J, Ha HJ, Ghantous F, Herrmann T, Chang W, Liu Z, Frey G, Seaman MS, Chen B, Chou JJ. Structural Basis for Membrane Anchoring of HIV-1 Envelope Spike. Science. 2016;353:172\u201375.", "ArticleIdList": ["PMC5085267", "27338706"]}, {"Citation": "Zhou GP, Troy FA., 2nd Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions. Glycobiology. 2003;13:51\u201371.", "ArticleIdList": ["12626407"]}, {"Citation": "Zhou GP, Huang RB, Troy FA., 2nd 3D structural conformation and functional domains of polysialyltransferase ST8Sia IV required for polysialylation of neural cell adhesion molecules. Protein Pept Lett. 2015;22:137\u2013148.", "ArticleIdList": ["25329332"]}, {"Citation": "Zhou GP, Zhong WZ. Perspectives in Medicinal Chemistry. Curr Top Med Chem. 2016;16:381\u2013382.", "ArticleIdList": ["26471864"]}, {"Citation": "Carter DB. A model for structure dependent binding of Congo Red to Alzeheimer beta-amyloid fibrils. Neurobiol Aging. 1998;19:37\u201340.", "ArticleIdList": ["9562501"]}, {"Citation": "Chou KC. Modeling the tertiary structure of human cathepsin-E. Biochem Biophys Res Commun. 2005;331:56\u201360.", "ArticleIdList": ["15845357"]}, {"Citation": "Chou KC, Howe WJ. Prediction of the tertiary structure of the beta-secretase zymogen. Biochem Biophys Res Commun. 2002;292:702\u201308.", "ArticleIdList": ["11922623"]}, {"Citation": "Watenpaugh KD, Heinrikson RL. A Model of the complex between cyclin-dependent kinase 5 (Cdk5) and the activation domain of neuronal Cdk5 activator. Biochem Biophys Res Commun. 1999;259:420\u2013428.", "ArticleIdList": ["10362524"]}, {"Citation": "Wei DQ, Sirois S, Du QS, Arias HR, Chou KC. Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives. Biochem Biophys Res Commun. 2005;338:1059\u201364.", "ArticleIdList": ["16256952"]}, {"Citation": "Chou KC. Structural bioinformatics and its impact to biomedical science. Curr Med Chem. 2004;11:2105\u20132134.", "ArticleIdList": ["15279552"]}, {"Citation": "Jones D, Heinrikson RL. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett. 1997;419:49\u201354.", "ArticleIdList": ["9426218"]}, {"Citation": "Chou JJ, Matsuo H, Duan H, Wagner G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell. 1998;94:171\u2013180.", "ArticleIdList": ["9695946"]}, {"Citation": "Chou JJ, Li H, Salvessen GS, Yuan J, Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signalling. Cell. 1999;96:615\u2013624.", "ArticleIdList": ["10089877"]}, {"Citation": "Tomasselli AG, Heinrikson RL. Prediction of the Tertiary Structure of a Caspase-9/Inhibitor Complex. FEBS Lett. 2000;470:249\u2013256.", "ArticleIdList": ["10745077"]}, {"Citation": "Chou KC. Insights from modeling the tertiary structure of human BACE2. J Proteome Res. 2004;3:1069\u201372.", "ArticleIdList": ["15473697"]}, {"Citation": "Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1\u201340) in cultured hippocampal neurons. Exp Neurol. 1995;131:193\u2013202.", "ArticleIdList": ["7895820"]}, {"Citation": "Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u201356.", "ArticleIdList": ["12130773"]}, {"Citation": "Bartus RT, Dean RL, 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408\u201314.", "ArticleIdList": ["7046051"]}, {"Citation": "Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, Kornhuber J, Wiltfang L. Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease - Original data and review of the literature. J Mol Neurosci. 2004;23:115\u2013122.", "ArticleIdList": ["15126697"]}, {"Citation": "Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J, The Tacrine Study Group A controlled trial of tacrine in Alzheimer's disease. JAMA. 1992;268:2523\u201329.", "ArticleIdList": ["1404819"]}, {"Citation": "Rogers SL, Friedhoff LT. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. Br J Clin Pharmacol. 1998;46:1\u20136.", "ArticleIdList": ["PMC1873812", "9839758"]}, {"Citation": "R\u00f6sler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, St\u00e4helin HB, Hartman R, Gharabawi M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. 1999;318:633\u201338.", "ArticleIdList": ["PMC27767", "10066203"]}, {"Citation": "Zarotsky V, Sramek JJ, Cutler NR. Galantamine hydrobromide: An agent for Alzheimer's disease. Am J Health Syst Pharm. 2003;60:446\u2013452.", "ArticleIdList": ["12635450"]}, {"Citation": "Choi YH, Yon GH, Hong KS, Yoo DS, Choi CW, Park WK, Kong JY, Kim YS, Ryu SY. In vitro BACE-1 Inhibitory Phenolic Components from the Seeds of Psoralea corylifolia. Planta Med. 2008;74:1405\u20131408.", "ArticleIdList": ["18666047"]}, {"Citation": "Lv L, Yang QY, Zhao Y, Yao CS, Sun Y, Yang EJ, Song KS, Mook-Jung I, Fang WS. BACE1 (beta-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis. Planta Med. 2008;74:540\u2013545.", "ArticleIdList": ["18543151"]}, {"Citation": "Rauter AP, Branco I, Lopes RG, Justino J, Silva FV, Noronha JP, Cabrita EJ, Brouard I, Bermejo J. A new lupene triterpenetriol and anticholinesterase activity of Salvia sclareoides. Fitoterapia. 2007;78:474\u2013481.", "ArticleIdList": ["17570616"]}, {"Citation": "Wang H, Tang XC. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Zhongguo Yao Li Xue Bao. 1998;19:27\u201330.", "ArticleIdList": ["10375753"]}, {"Citation": "Scott LJ, Goa KL. Galantamine - A review of its use in Alzheimer's disease. Drugs. 2000;60:1095\u20131122.", "ArticleIdList": ["11129124"]}, {"Citation": "Yoshida S, Suzuki N. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. Eur J Pharmacol. 1993;250:117\u2013124.", "ArticleIdList": ["8119309"]}, {"Citation": "Wei X, Jiang JS, Feng ZM, Zhang PC. Anthraquinone-benzisochromanquinone dimers from the roots of Berchemia floribunda. Chem Pharm Bull (Tokyo) 2008;56:1248\u201352.", "ArticleIdList": ["18758095"]}, {"Citation": "Brown MP, Royer C. Fluorescence spectroscopy as a tool to investigate protein interactions. Curr Opin Biotechnol. 1997;8:45\u20139.", "ArticleIdList": ["9013650"]}, {"Citation": "Croney JC, Jameson DM, Learmonth RP. Fluorescence spectroscopy in biochemistry: teaching basic principles with visual demonstrations. Biochem Mol Biol Educ. 2001;29:60\u201365."}, {"Citation": "Ewing GW. Practical hints on absorption spectrometry (ultraviolet and visible) J Chem Educ. 1969;46:A122."}, {"Citation": "Gillard RD. Circular dichroism. A review. Analyst (Lond) 1963;88:825\u201328."}, {"Citation": "Chou KC, Wei DQ, Zhong WZ. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun. 2003;308:148\u2013151. (Erratum: ibid. 2003, Vol.310, 675)", "ArticleIdList": ["PMC7111004", "12890493"]}, {"Citation": "Liao QH, Gao QZ, Wei J. Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR) Med Chem. 2011;7:24\u201331.", "ArticleIdList": ["21235516"]}, {"Citation": "Li XB, Wang SQ, Xu WR, Wang RL. Novel Inhibitor Design for Hemagglutinin against H1N1 Influenza Virus by Core Hopping Method. PLoS One. 2011;6:e28111.", "ArticleIdList": ["PMC3227604", "22140516"]}, {"Citation": "Wang JF, Wei DQ. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem Biophys Res Commun. 2009;388:413\u2013417.", "ArticleIdList": ["19665993"]}, {"Citation": "Zhang T, Wei DQ. A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA. Med Chem. 2012;8:198\u2013207.", "ArticleIdList": ["22385179"]}, {"Citation": "Du QS, Wang S, Wei DQ, Sirois S, Chou KC. Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro. Anal Biochem. 2005;337:262\u2013270.", "ArticleIdList": ["PMC7094278", "15691506"]}, {"Citation": "Huang RB, Du QS, Wang CH, Chou KC. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem Biophys Res Commun. 2008;377:1243\u201347.", "ArticleIdList": ["18996090"]}, {"Citation": "Du QS, Huang RB, Wang CH, Li XM. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J Theor Biol. 2009;259:159\u2013164.", "ArticleIdList": ["19285514"]}, {"Citation": "Du QS, Huang RB, Wang SQ. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus. PLoS One. 2010;5:e9388.", "ArticleIdList": ["PMC2826421", "20186344"]}, {"Citation": "Wang SQ, Du QS, Huang RB, Zhang DW. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Commun. 2009;386:432\u2013436.", "ArticleIdList": ["19523442"]}, {"Citation": "Cai L, Wang Y, Wang JF. Identification of proteins interacting with human SP110 during the process of viral infections. Med Chem. 2011;7:121\u2013126.", "ArticleIdList": ["21222611"]}, {"Citation": "Ma Y, Wang SQ, Xu WR, Wang RL. Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach. PLoS One. 2012;7:e38546.", "ArticleIdList": ["PMC3369836", "22685582"]}, {"Citation": "Wang JF. Insights from modeling the 3D structure of New Delhi metallo-beta-lactamase and its binding interactions with antibiotic drugs. PLoS One. 2011;6:e18414.", "ArticleIdList": ["PMC3073942", "21494599"]}, {"Citation": "Wang JF, Chou KC. Insights into the Mutation-Induced HHH Syndrome from Modeling Human Mitochondrial Ornithine Transporter-1. PLoS One. 2012;7:e31048.", "ArticleIdList": ["PMC3266937", "22292090"]}, {"Citation": "Chou KC. Impacts of bioinformatics to medicinal chemistry. Med Chem. 2015;11:218\u2013234.", "ArticleIdList": ["25548930"]}, {"Citation": "Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395.", "ArticleIdList": ["13726518"]}, {"Citation": "Bourassaa P, Dubeaua S, Maharvi GM, Fauq AH, Thomas TJ, Tajmir-Riahi HA. Binding of antitumor tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen to human serum albumin. Biochimie. 2011;93:1089\u20131101.", "ArticleIdList": ["21439346"]}, {"Citation": "Mohammadi F, Bordbar AK, Divsalar A, Mohammadi K, Saboury AA. Interaction of Curcumin and Diacetylcurcumin with the Lipocalin Member \u03b2-Lactoglobulin. Protein J. 2009;28:117\u201323.", "ArticleIdList": ["19189206"]}, {"Citation": "Lakowicz JR, Masters BR. Principles of Fluorescence Spectroscopy, Third Edition. J Biomed Opt. 2008:029901."}, {"Citation": "Bi S, Song D, Tian Y, Zhou X, Liu Z, Zhang H. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta A Mol Biomol Spectrosc. 2005;61:629\u2013636.", "ArticleIdList": ["15649793"]}, {"Citation": "Kandagal PB, Ashoka S, Seetharamappa J, Shaikh SM, Jadegoud Y, Ijare OB. Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J Pharm Biomed Anal. 2006;41:393\u201399.", "ArticleIdList": ["16413740"]}, {"Citation": "Xie MX, Xu XY, Wang YD. Interaction between hesperetin and human serum albumin revealed by spectroscopic methods. Biochim Biophys Acta. 2005;1724:215\u201324.", "ArticleIdList": ["15923087"]}, {"Citation": "F\u00f6rster T. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann Phys. 1948;437:55\u201375."}, {"Citation": "Chen X, Qian K, Chen Q. Comparison between loureirin A and cochinchinenin C on the interaction with human serum albumin. Eur J Med Chem. 2015;93:492\u2013500.", "ArticleIdList": ["25734332"]}, {"Citation": "Berde CB, Hudson BS, Simoni RD, Sklar LA. Human serum albumin. Spectroscopic studies of binding and proximity relationships for fatty acids and bilirubin. J Biol Chem. 1979;254:391\u2013400.", "ArticleIdList": ["216673"]}, {"Citation": "Epps DE, Raub TJ, Caiolfa V, Chiari A, Zamai M. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein. J Pharm Pharmacol. 1999;51:41\u201348.", "ArticleIdList": ["10197416"]}, {"Citation": "Chen NY. The biological functions of low-frequency phonons. Sci Sin. 1977;20:447\u2013457."}, {"Citation": "Chen NY, Forsen S. The biological functions of low-frequency phonons: 2. Cooperative effects. Chem Scr. 1981;18:126\u2013132."}, {"Citation": "Chou KC. The biological functions of low-frequency vibrations (phonons). 4. Resonance effects and allosteric transition. Biophys Chem. 1984;20:61\u201371.", "ArticleIdList": ["6487745"]}, {"Citation": "Chou KC. The biological functions of low-frequency vibrations (phonons). VI. A possible dynamic mechanism of allosteric transition in antibody molecules. Biopolymers. 1987;26:285\u2013295.", "ArticleIdList": ["3828475"]}, {"Citation": "Mao B. Collective motion in DNA and its role in drug intercalation. Biopolymers. 1988;27:1795\u20131815.", "ArticleIdList": ["3233332"]}, {"Citation": "Chou KC. Low-frequency resonance and cooperativity of hemoglobin. Trends Biochem Sci. 1989;14:212\u2013213.", "ArticleIdList": ["2763333"]}, {"Citation": "Chou KC. Review: Low-frequency collective motion in biomacromolecules and its biological functions. Biophys Chem. 1988;30:3\u201348.", "ArticleIdList": ["3046672"]}, {"Citation": "Chou KC. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. J Proteome Res. 2005;4:1681\u20131686.", "ArticleIdList": ["16212421"]}, {"Citation": "Zhou GP, Troy FA. NMR studies on how the binding complex of polyisoprenol recognition sequence peptides and polyisoprenols can modulate membrane structure. Curr Protein Pept Sci. 2005;6:399\u2013411.", "ArticleIdList": ["16248792"]}, {"Citation": "Wei DQ, Du QS, Sirois S, Zhong WZ. Review: Progress in computational approach to drug development against SARS. Curr Med Chem. 2006;13:3263\u20133270.", "ArticleIdList": ["17168850"]}, {"Citation": "Wei H, Wang CH, Du QS, Meng J. Investigation into adamantane-based M2 inhibitors with FB-QSAR. Med Chem. 2009;5:305\u2013317.", "ArticleIdList": ["19689387"]}, {"Citation": "Bourne Y, Taylor P, Radic Z, Marchot P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. 2003;22:1\u201312.", "ArticleIdList": ["PMC140045", "12505979"]}, {"Citation": "Castro A, Martinez A. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease. Mini Rev Med Chem. 2001;1:267\u2013272.", "ArticleIdList": ["12369973"]}, {"Citation": "Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL. Acetylcholinesterase: From 3D structure to function. Chem Biol Interact. 2010;187:10\u201322.", "ArticleIdList": ["PMC2894301", "20138030"]}, {"Citation": "Zhang CT. Review: Prediction of protein structural classes. Crit Rev Biochem Mol Biol. 1995;30:275\u2013349.", "ArticleIdList": ["7587280"]}, {"Citation": "Ronco C, Sorin G, Nachon F, Foucault R, Jean L, Romieu A, Renard PY. Synthesis and structure-activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors. Bioorg Med Chem. 2009;17:4523\u20134536.", "ArticleIdList": ["19473849"]}, {"Citation": "Cramer RD. Topomer CoMFA: A design methodology for rapid lead optimization. J Med Chem. 2003;46:374\u2013388.", "ArticleIdList": ["12540237"]}, {"Citation": "Rosini M, Andrisano V, Bartolini M, Bolognesi M, Hrelia P, Minarini A, Tarozzi A, Melchiorre C. Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem. 2005;48:360\u2013363.", "ArticleIdList": ["15658850"]}, {"Citation": "Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M, Cavrini V. SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues. J Med Chem. 2000;43:2007\u20132018.", "ArticleIdList": ["10821713"]}, {"Citation": "Rampa A, Piazzi L, Belluti F, Gobbi S, Bisi A, Bartolini M, Andrisano V, Cavrini V, Cavalli A, Recanatini M, Valenti P. Acetylcholinesterase inhibitors: SAR and kinetic studies on \u03c9-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives. J Med Chem. 2001;44:3810\u201320.", "ArticleIdList": ["11689067"]}, {"Citation": "Camps P, Formosa X, Galdeano C, Gomez T, Munoz-Torrero D, Scarpellini M, Viayna E, Badia A, Clos MV, Camins A, Pallas M, Bartolini M, Mancini F, et al. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced \u03b2-amyloid aggregation. J Med Chem. 2008;51:3588\u20133598.", "ArticleIdList": ["18517184"]}, {"Citation": "Piazzi L, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, Andrisano V, Recanatini M, Rampa A. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. Bioorg Med Chem. 2007;15:575\u2013585.", "ArticleIdList": ["17008100"]}, {"Citation": "Elsinghorst PW, Tanarro CM, G\u00fctschow M. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. J Med Chem. 2006;49:7540\u20137544.", "ArticleIdList": ["17149883"]}, {"Citation": "Du QS, Huang RB, Wei YT, Du LQ. Multiple Field Three Dimensional Quantitative Structure-Activity Relationship (MF-3D-QSAR) J Comput Chem. 2008;29:211\u2013219.", "ArticleIdList": ["17559075"]}, {"Citation": "Xu Y, Ding J, Wu LY. iSNO-PseAAC: Predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One. 2013;8:e55844.", "ArticleIdList": ["PMC3567014", "23409062"]}, {"Citation": "Chen W, Tang H, Ye J, Lin H. iRNA-PseU: Identifying RNA pseudouridine sites. Mol Ther Nucleic Acids. 2016;5:e332.", "ArticleIdList": ["PMC5330936", "28427142"]}, {"Citation": "Feng P, Ding H, Yang H, Chen W, Lin H. iRNA-PseColl: Identifying the occurrence sites of different RNA modifications by incorporating collective effects of nucleotides into PseKNC. Mol Ther Nucleic Acids. 2017;7:155\u2013163.", "ArticleIdList": ["PMC5415964", "28624191"]}, {"Citation": "Liu B, Yang F. A two-layer ensemble classifier for identifying piwi-interacting RNAs and their function. Mol Ther Nucleic Acids. 2017;7:267\u2013277.", "ArticleIdList": ["PMC5415553", "28624202"]}, {"Citation": "Xu Y, Wen X, Wen LS, Wu LY, Deng NY. iNitro-Tyr: Prediction of nitrotyrosine sites in proteins with general pseudo amino acid composition. PLoS One. 2014;9:e105018.", "ArticleIdList": ["PMC4133382", "25121969"]}, {"Citation": "Chen W, Feng P, Yang H, Ding H, Lin H, Chou KC. iRNA-AI: identifying the adenosine to inosine editing sites in RNA sequences. Oncotarget. 2017;8:4208\u201317.  https://doi.org/10.18632/oncotarget.13758.", "ArticleIdList": ["10.18632/oncotarget.13758", "PMC5354824", "27926534"]}, {"Citation": "Cheng X, Zhao SG, Xiao X, Chou KC. iATC-mHyb: a hybrid multi-label classifier for predicting the classification of anatomical therapeutic chemicals. Oncotarget. 2017 Apr;11  https://doi.org/10.18632/oncotarget.17028 [Epub ahead of print]", "ArticleIdList": ["10.18632/oncotarget.17028", "PMC5601669", "28938573"]}, {"Citation": "Qiu WR, Jiang SY, Xu ZC, Xiao X, Chou KC. iRNAm5C-PseDNC: identifying RNA 5-methylcytosine sites by incorporating physical-chemical properties into pseudo dinucleotide composition. Oncotarget. 2017;8:41178\u201388.  https://doi.org/10.18632/oncotarget.17104.", "ArticleIdList": ["10.18632/oncotarget.17104", "PMC5522291", "28476023"]}, {"Citation": "Xu Y, Shao XJ, Wu LY, Deng NY. iSNO-AAPair: incorporating amino acid pairwise coupling into PseAAC for predicting cysteine S-nitrosylation sites in proteins. PeerJ. 2013;1:e171.", "ArticleIdList": ["PMC3792191", "24109555"]}, {"Citation": "Zhang CJ, Tang H, Li WC, Lin H, Chen W, Chou KC. iOri-Human: identify human origin of replication by incorporating dinucleotide physicochemical properties into pseudo nucleotide composition. Oncotarget. 2016;7:69783\u201393.  https://doi.org/10.18632/oncotarget.11975.", "ArticleIdList": ["10.18632/oncotarget.11975", "PMC5342515", "27626500"]}, {"Citation": "Liu LM, Xu Y. iPGK-PseAAC: identify lysine phosphoglycerylation sites in proteins by incorporating four different tiers of amino acid pairwise coupling information into the general PseAAC. Med Chem. 2017 May 15;  https://doi.org/10.2174/1573406413666170515120507 [Epub ahead of print]", "ArticleIdList": ["10.2174/1573406413666170515120507", "28521678"]}, {"Citation": "Jia J, Liu Z, Xiao X, Liu B. pSuc-Lys: Predict lysine succinylation sites in proteins with PseAAC and ensemble random forest approach. J Theor Biol. 2016;394:223\u2013230.", "ArticleIdList": ["26807806"]}, {"Citation": "Cheng X, Zhao SG, Xiao X. iATC-mISF: a multi-label classifier for predicting the classes of anatomical therapeutic chemicals. Bioinformatics. 2017;33:341\u2013346.", "ArticleIdList": ["28172617"]}, {"Citation": "Liu B, Wang S, Long R. iRSpot-EL: identify recombination spots with an ensemble learning approach. Bioinformatics. 2017;33:35\u201341.", "ArticleIdList": ["27531102"]}, {"Citation": "Xu Y, Wang Z, Li C, Chou KC. iPreny-PseAAC: identify C-terminal cysteine prenylation sites in proteins by incorporating two tiers of sequence couplings into PseAAC. Med Chem. 2017 Apr;19  https://doi.org/10.2174/1573406413666170419150052 [Epub ahead of print]", "ArticleIdList": ["10.2174/1573406413666170419150052", "28425870"]}, {"Citation": "Qiu WR, Jiang SY, Sun BQ, Xiao X, Cheng X, Chou KC. iRNA-2methyl: identify RNA 2\u2032-O-methylation sites by incorporating sequence-coupled effects into general PseKNC and ensemble classifier. Med Chem. 2017 Jun;22  https://doi.org/10.2174/1573406413666170623082245 [Epub ahead of print]", "ArticleIdList": ["10.2174/1573406413666170623082245", "28641529"]}, {"Citation": "Cheng X, Xiao X, Chou KC. pLoc-mPlant: predict subcellular localization of multi-location plant proteins by incorporating the optimal GO information into general PseAAC. Mol Biosyst. 2017 Jul;12  https://doi.org/10.1039/c7mb00267j [Epub ahead of print]", "ArticleIdList": ["10.1039/c7mb00267j", "28702580"]}, {"Citation": "Shen HB. Recent advances in developing web-servers for predicting protein attributes. Nat Sci. 2009;1:63\u201392."}]}], "History": [{"Year": "2017", "Month": "5", "Day": "7"}, {"Year": "2017", "Month": "6", "Day": "28"}, {"Year": "2017", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "8", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["28915661", "PMC5593632", "10.18632/oncotarget.19169", "19169"]}}]}